Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02899117
Other study ID # Pilot Yoga 1
Secondary ID
Status Completed
Phase N/A
First received August 23, 2016
Last updated February 15, 2017
Start date August 2014
Est. completion date January 2017

Study information

Verified date February 2017
Source Connecticut Children's Medical Center
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The proposed project will examine feasibility and preliminary efficacy of a yoga intervention in the pediatric oncology unit at Connecticut Children's Medical Center (CCMC) and includes two parts: (1) a survey of children and parents regarding preferences (e.g., convenient days/times), experiences and expectations regarding yoga (including barriers and positive expectancies) and (2) an eight week clinical trial of a yoga intervention in 10 pairs of children and parents.


Description:

The specific aims and hypotheses for this seed grant are to collect and assess data on:

Aim 1 feasibility - perceived barriers/solutions, interest and accrual rates, attendance per session, participant retention, evidence of institutional support and resource commitment Hypothesis 1: A yoga intervention is feasible among pediatric oncology patients and their parents; (2) preliminary efficacy - including effect sizes for calculating power Hypothesis 2a: A yoga intervention improves pediatric oncology patients' fatigue, QOL, and sleep.

Hypothesis 2b: A yoga intervention improves parental QOL and caregiver burden.

We will be using the following questionnaires and scales to help answer the quesitons related to the hypotheses and aims:

PedsQL 4.0 PedsQL 3.0 Cancer Module The Fatigue Scale SleepDiary Actigraphy data. Child Home Yoga Practice Diary Satisfaction survey

Questionnaires noted below are given only to the parents:

SF-12 Zarit Caregiver Burden Index Yoga Satisfaction Survey

Study participants will have 4 yoga sessions and the questionnaires and surveys are done prior to the first yoga session and after the last yoga session.

The yoga sessions are created with both the study participant and a certified yoga instructor. The patients are given the yoga routine to practice at home at their leisure.


Recruitment information / eligibility

Status Completed
Enrollment 23
Est. completion date January 2017
Est. primary completion date October 2016
Accepts healthy volunteers No
Gender All
Age group 8 Years to 18 Years
Eligibility Inclusion Criteria:

- Parents and children (ages 8-18) undergoing treatment (chemotherapy and/or radiation therapy) for cancer.

- Cancer diagnosis, between the ages of 8-18 year, English speaking, and medically cleared to participate in yoga.

- Parents will be eligible if they are over 18 years old, English speaking, and physically able to participate in yoga.

Exclusion Criteria:

- Children and parents not meeting inclusion criteria

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Yoga
There are 4 yoga sessions completed with a certified instructor during cancer treatment

Locations

Country Name City State
United States Connecticut Children's Medical Center Hartford Connecticut

Sponsors (1)

Lead Sponsor Collaborator
Connecticut Children's Medical Center

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Feasibility of yoga intervention, perceived barriers/solutions The data will be assessed on perceived barriers/solutions. Change from baseline barriers/solutions at 8 weeks post baseline visit
Primary Assess level of interest utlizing data from the Yoga satisfaction survey Data will be assessed by level of interest utilizing data from the yoga satisfcation survey. Most responses will be on a Likert scale while some specific questions will be other formats (i.e. open ended questions). These questions will help to inform the intervention. Data collected at baseline and 8 weeks post baseline visit
Primary Feasibility of yoga intervention, assessed by study accrual rates Data will be assessed by accrual rates Baseline and 8 weeks post baseline visit
Primary Feasibility of yoga intervention, assessed by study visit attendance Data will be assessed by study visit attendance Baseline and 8 weeks post baseline visit
Primary Feasibility of yoga intervention, assessed by study patient retention Data will be assessed by the number of patients who remain in the study Baseline and 8 weeks post baseline visit
Primary Feasibility of yoga intervention, assessed by institutional support Data will be reviewed for evidence of institutional support Baseline and 8 weeks post baseline visit
Primary Feasibility of yoga intervention, assessed by institutional commitment of resources. Data will be reviewed for institutional resource commitment Assessments are collected at baseline and 8 weeks post baseline visit
Secondary Improvement in sleep of Patient Sleep will be assessed via diary of sleep and actigraphy Assessments are collected at baseline and 8 weeks post baseline visit
Secondary Improvement in quality of life Patient Quality of life will be assessed by PedsQL 4.0 and PedsQL 3.0 Cancer Module. Assessments are collected at baseline and 8 weeks post baseline visit
Secondary Improvement in fatigue of Patient Fatigue will be assessed by the Fatigue Scale (FS). The Fatigue Scale for children (FS-C) between 8-12 years and the Fatigue Scale for adolescent (FS-A) between 13-18 years. Assessments are collected at baseline and 8 weeks post baseline visit
Secondary Improvement in quality of life of Parent Parent quality of life will be assessed by the SF-12. Assessments are collected at baseline and 8 weeks post baseline visit
Secondary Improvement in caregiver burden of Parent. Caregiver burden will be assessed by the Zarit Caregiver Burden Index Assessments are collected at baseline and 8 weeks post baseline visit
See also
  Status Clinical Trial Phase
Completed NCT03826043 - THrombo-Embolic Event in Onco-hematology N/A
Terminated NCT03166631 - A Trial to Find the Safe Dose for BI 891065 Alone and in Combination With BI 754091 in Patients With Incurable Tumours or Tumours That Have Spread Phase 1
Completed NCT01938846 - BI 860585 Dose Escalation Single Agent and in Combination With Exemestane or With Paclitaxel in Patients With Various Advanced and/or Metastatic Solid Tumors Phase 1
Recruiting NCT06058312 - Individual Food Preferences for the Mediterranean Diet in Cancer Patients N/A
Completed NCT03308942 - Effects of Single Agent Niraparib and Niraparib Plus Programmed Cell Death-1 (PD-1) Inhibitors in Non-Small Cell Lung Cancer Participants Phase 2
Recruiting NCT06018311 - Exercising Together for Hispanic Prostate Cancer Survivor-Caregiver Dyads N/A
Withdrawn NCT05431439 - Omics of Cancer: OncoGenomics
Completed NCT01343043 - A Pilot Study of Genetically Engineered NY-ESO-1 Specific NY-ESO-1ᶜ²⁵⁹T in HLA-A2+ Patients With Synovial Sarcoma Phase 1
Completed NCT01938638 - Open Label Phase I Dose Escalation Study With BAY1143572 in Patients With Advanced Cancer Phase 1
Recruiting NCT05514444 - Study of MK-4464 as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced/Metastatic Solid Tumors (MK-4464-001) Phase 1
Recruiting NCT02292641 - Beyond TME Origins N/A
Terminated NCT00954512 - Study of Robatumumab (SCH 717454, MK-7454) in Combination With Different Treatment Regimens in Participants With Advanced Solid Tumors (P04722, MK-7454-004) Phase 1/Phase 2
Recruiting NCT04958239 - A Study to Test Different Doses of BI 765179 Alone and in Combination With Ezabenlimab in Patients With Advanced Cancer (Solid Tumors) Phase 1
Recruiting NCT04627376 - Multimodal Program for Cancer Related Cachexia Prevention N/A
Completed NCT01222728 - Using Positron Emission Tomography to Predict Intracranial Tumor Growth in Neurofibromatosis Type II Patients
Recruiting NCT06004440 - Real World Registry for Use of the Ion Endoluminal System
Active, not recruiting NCT05636696 - COMPANION: A Couple Intervention Targeting Cancer-related Fatigue N/A
Not yet recruiting NCT06035549 - Resilience in East Asian Immigrants for Advance Care Planning Discussions N/A
Recruiting NCT06004466 - Noninvasive Internal Jugular Venous Oximetry
Not yet recruiting NCT02806557 - Profiling Neutrophil Counts in Patients on Chemotherapy N/A